Learn / MPLT
NASDAQ: MPLT
MapLight Therapeutics (MPLT) stock, explained like you're 5
MapLight Therapeutics trades on the Nasdaq under the ticker MPLT. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 572 million dollars.
- Ticker
- MPLT
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 572 million dollars
Is MapLight Therapeutics a small, medium or large cap company?
No. MapLight Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 572 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How MapLight Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves MPLT stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- MapLight Therapeutics, Inc. (MPLT) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- MPLT Stock Plunges 73% Wipes Out Over $1B In Market Cap After Trial Miss On Once Daily Dose (Stocktwits)
- Maplight Therapeutics (NASDAQ:MPLT) CFO Sells $82,149.36 in Stock (MarketBeat)
- MapLight Therapeutics’ Kreitzer sells $96,024 in common stock By Investing.com (Investing.com Nigeria)
- Down 29.2% in 4 Weeks, Here's Why You Should You Buy the Dip in MapLight Therapeutics, Inc. (MPLT) (Yahoo! Finance Canada)
Follow MPLT in your daily brief
Each trading day at 5 PM ET we post what happened to MapLight Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow MPLT
Questions about MapLight Therapeutics stock
What does MapLight Therapeutics do?
MapLight Therapeutics trades on the Nasdaq under the ticker MPLT. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 572 million dollars.
What is the ticker symbol for MapLight Therapeutics?
MapLight Therapeutics trades under the ticker MPLT on the Nasdaq.
What is MapLight Therapeutics's market cap?
MapLight Therapeutics is a small cap stock with a market cap of about 572 million dollars.
How does MapLight Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves MPLT stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow MPLT stock every day?
Add MPLT to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.